Skip to main content

Table 1 Investigations at initial presentation and subsequent follow-up. Abnormal results are shown in bold. N/A = not available

From: Cerebral toxoplasmosis in a patient with myasthenia gravis and thymoma with immunodeficiency/Good’s syndrome: a case report

Analyte

Value

Reference Range

Sodium

141

135–145 mmol/L

Potassium

4.4

3.5–5

Chloride

103

97–109

Bicarbonate

23

24–32

Urea

4.8

3–8 mmol/L

Creatinine

72

50-90micromol/L

Bilirubin

16

<21micromol/L

Albumin

37

38–48 g/L

Protein

61

62–80 g/L

ALP

43

30–130U/L

GGT

11

<35U/L

ALT

23

5–55U/L

AST

28

5–55U/L

WCC

7.9

4–10 × 109/L

Hb

143

120–150 g/L

Platelets

300

150–400 × 109/L

Neutrophils

7

2–7 × 109/L

Lymphocytes

0.7

1–3 ×109/L

Monocytes

0.1

0.2–1 ×109/L

Eosinophils

0

0.0–0.1 ×109/L

Basophils

0

N/A

Cryptococcal antigen

Negative

N/A

HIV-1/2 Ag/Ab test

Negative

N/A

IgG

11.1

6.39–15.6 g/L

IgA

0.73

0.7–3.12 g/L

IgM

0.47

0.5–3 g/L

IgD

<0.01

0.01–0.14 g/L

IgE

<2kU/L

0–120kU/L

CD3+ T-cell

0.81 × 10^9

1.2–2.7 × 109

CD3 + T-cell (%)

90 %

58–85 %

CD19+ B-cell

0

4–19 %

CD19+ B-cell (%)

0

0.05–0.41 × 109/L

CD4+ T-cell

0.38 × 10^9

0.4–1.32 × 109/L

CD4+ T-cell (%)

42

31–58 %

CD8+ T-cell

0.41 × 10^9

0.22–0.74 × 109/L

CD8 + T-cell (%)

46 %

11–37 %

CD16/56+ NK Cell

10 × 10^9

N/A

CD16/56+ NK Cell (%)

11

N/A